Intrinsic Value of S&P & Nasdaq Contact Us

Tyra Biosciences, Inc. TYRA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
53/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$49.80
+41.2%

Stock Statistics — TYRA

Tyra Biosciences, Inc. (TYRA) has a market capitalization of $1.89B and trades at $35.27. The 52-week range is 6.42-40.65.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -17.5, Earnings Per Share (EPS) of $-2.01.

The stock has a beta of 0.96, operates in the Healthcare sector.

Trading Data
Current Price$35.27
52-Week Range6.42-40.65
Volume1.39M
Avg Volume (30D)1.01M
Market Cap$1.89B
Beta (1Y)0.96
Company
IPO Date2021-09-15
Employees60
CEOTodd Harris
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS90240B1061
CUSIP90240B106
Income (Latest Year)
Gross Profit$-546K
EBITDA$-119.4M
Operating Income$-132.76M
Net Income$-119.95M
EPS$-2.01
EPS Diluted$-2.01
Shares Outstanding$59.6M
Balance Sheet (Latest Year)
Total Assets$282.61M
Current Assets$265.45M
Cash & ST Investments$256M
Total Liabilities$23.43M
Total Debt$5.81M
Net Debt$-71.58M
Total Equity$259.18M
Debt / Equity0.02
Valuation Ratios
P/E Ratio-17.5
P/B Ratio7.31
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message